Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1971 Oct;34(5):527–530. doi: 10.1136/jnnp.34.5.527

Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy

R C Hughes 1, Dorothy C Park 1, Mary E Parsons 1, M D O'Brifn 1
PMCID: PMC493863  PMID: 4941478

Abstract

A number of methods which might improve the detection of carriers of Duchenne muscular dystrophy, based on the estimation of serum creatine kinase (CK), have been tried in an attempt to improve the 70% detection rate obtained with random samples. One series of experiments involved controlled exercise on a bicycle ergometer, the second series was based on sampling of muscle venous blood after controlled ischaemic exercise, and a third series of experiments was carried out to see whether the rate of enzyme inactivation was different in carriers of Duchenne dystrophy compared with controls. These methods were not found to improve the carrier detection rate based upon serum CK estimation.

Full text

PDF
527

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLAHD W. H., CASSEN B., LEDERER M. DECREASED BODY POTASSIUM IN NONDYSTROPHIC RELATIVES OF PATIENTS WITH MUSCULAR DYSTROPHY. A BIOCHEMICAL TRAIT. N Engl J Med. 1964 Jan 23;270:197–198. doi: 10.1056/NEJM196401232700408. [DOI] [PubMed] [Google Scholar]
  2. Blahd W. H., Lederer M., Cassen B. The significance of decreased body potassium concentrations in patients with muscular dystrophy and nondystrophic relatives. N Engl J Med. 1967 Jun 15;276(24):1349–1352. doi: 10.1056/NEJM196706152762404. [DOI] [PubMed] [Google Scholar]
  3. Emery A. E. Genetic counselling in X-linked muscular dystrophy. J Neurol Sci. 1969 May-Jun;8(3):579–587. doi: 10.1016/0022-510x(69)90016-1. [DOI] [PubMed] [Google Scholar]
  4. Gardner-Medwin D. Studies of the carrier state in the Duchenne type of muscular dystrophy. 2. Quantitative electromyography as a method of carrier detection. J Neurol Neurosurg Psychiatry. 1968 Apr;31(2):124–134. doi: 10.1136/jnnp.31.2.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Griffiths P. D. Serum levels of ATP: creatine phosphotransferase (creatine kinase). The normal range and effect of muscular activity. Clin Chim Acta. 1966 Apr;13(4):413–420. doi: 10.1016/0009-8981(66)90230-0. [DOI] [PubMed] [Google Scholar]
  6. Hudgson P., Gardner-Medwin D., Pennington R. J., Walton J. N. Studies of the carrier state in the Duchenne type of muscular dystrophy. I. Effect of exercise on serum creatine kinase activity. J Neurol Neurosurg Psychiatry. 1967 Oct;30(5):416–419. doi: 10.1136/jnnp.30.5.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Johnston H. A., Wilkinson J. H., Withycombe W. A., Raymond S. Alpha-hydroxybutyrate dehydrogenase activity in sex-linked muscular dystrophy. J Clin Pathol. 1966 May;19(3):250–256. doi: 10.1136/jcp.19.3.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lanari A., González Pérez M., Semeniuk G. B. Increased levels of serum-creatine-phosphokinase after transient limb ischaemia in patients with muscular dystrophy. Lancet. 1970 Jan 31;1(7640):217–218. doi: 10.1016/s0140-6736(70)90575-1. [DOI] [PubMed] [Google Scholar]
  9. PEARCE J. M., PENNINGTON R. J., WALTON J. N. SERUM ENZYME STUDIES IN MUSCLE DISEASE. I. VARIATIONS IN SERUM CREATINE KINASE ACTIVITY IN NORMAL INDIVIDUALS. J Neurol Neurosurg Psychiatry. 1964 Feb;27:1–4. doi: 10.1136/jnnp.27.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pearce G. W., Pearce J. M., Walton J. N. The Duchenne type muscular dystrophy: histopathological studies of the carrier state. Brain. 1966 Mar;89(1):109–120. doi: 10.1093/brain/89.1.109. [DOI] [PubMed] [Google Scholar]
  11. Roy S., Dubowitz V. Carrier detection in Duchenne muscular dystrophy. A comparative study of electron microscopy, light microscopy and serum enzymes. J Neurol Sci. 1970 Jul;11(1):65–79. doi: 10.1016/0022-510x(70)90041-9. [DOI] [PubMed] [Google Scholar]
  12. STEPHENS J., LEWIN E. SERUM ENZYME VARIATIONS AND HISTOLOGICAL ABNORMALITIES IN THE CARRIER STATE IN DUCHENNE DYSTROPHY. J Neurol Neurosurg Psychiatry. 1965 Apr;28:104–108. doi: 10.1136/jnnp.28.2.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Thomson W. H. Determination and statistical analyses of the normal ranges for five serum enzymes. Clin Chim Acta. 1968 Sep;21(3):469–478. doi: 10.1016/0009-8981(68)90078-8. [DOI] [PubMed] [Google Scholar]
  14. VEJJAJIVA A., TEASDALE G. M. SERUM CREATINE KINASE AND PHYSICAL EXERCISE. Br Med J. 1965 Jun 26;1(5451):1653–1654. doi: 10.1136/bmj.1.5451.1653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wiesmann U., Moser H., Richterich R., Rossi E. Progressive Muskeldystrophie. VII. Die Erfassung von Heterozygoten der Duchenne-Muskeldystrophie durch Messung der Serum-Kreatin-Kinase unter lokalisierter Arbeitsbelastung in Anoxie. Klin Wochenschr. 1965 Oct 1;43(19):1015–1022. doi: 10.1007/BF01746589. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES